Exact Mass: 660.241794
Exact Mass Matches: 660.241794
Found 87 metabolites which its exact mass value is equals to given mass value 660.241794,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Taccalonolide B
Taccalonolide B is a natural product found in Tacca plantaginea and Tacca chantrieri with data available. Taccalonolide B is microtubule stabilizer isolated from Tacca plantaginea, with antitumor activity. Taccalonolide B is effective in vitro against cell lines that overexpress P-glycoprotein (Pgp) and multidrug-resistance protein (MRP7). Taccalonolide B inhibits growth of SK-OV-3 cells with an IC50 of 208 nM[1][2]. Taccalonolide B is microtubule stabilizer isolated from Tacca plantaginea, with antitumor activity. Taccalonolide B is effective in vitro against cell lines that overexpress P-glycoprotein (Pgp) and multidrug-resistance protein (MRP7). Taccalonolide B inhibits growth of SK-OV-3 cells with an IC50 of 208 nM[1][2].
2)-rhamnoside
2''-O-Rhamnosylicariside II is a flavonoid glycoside compound and might be beneficial for improving postmenopausal osteoporosis.
Calyflorenone A
12-O-Deacetyltrichilin H
A limonoid isolated from the ripe fruits of Melia azedarach.
4-[6-O-(5-O-(dimethoxycinnamic acid)-beta-apiofuranosyl)-beta-glucopyranoside]-5-methylcoumarin
12-O-desacetyl-12-O-benzoylpteroidine
C34H41ClO11 (660.2337266000001)
2-O-RHAMNOSYLICARISIDE II
2''-O-Rhamnosylicariside II is a flavonoid glycoside compound and might be beneficial for improving postmenopausal osteoporosis.
5-hydroxy-7-(4-hydroxyphenyl)-2-methyl-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]pyrano[3,2-g]chromen-6-one
2,7-Bis(9H-fluoren-2-yl)-4,9-diphenylpyrido[2,3-g]quinoline
(-)-1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLANO)BENZENE(CYCLOOCTADIENE)RHODIUM(L)TETRAFLUOROBORATE
C30H48BF4P2Rh (660.2315275999999)
(R)-(+)-2,2-BIS(N-DIPHENYLPHOSPHINOAMINO)-5,5,6,6,7,7,8,8-OCTAHYDRO-1,1-BINAPHTHYL
C44H42N2P2 (660.2823072000001)
5-DMT-2-TBDMS-RU
5'-O-DMT-2'-TBDMS-Uridine is a deoxyribonucleoside used for the oligonucleotide synthesis.
butane-1,4-diol,1,3-diisocyanato-2-methylbenzene,hexanedioic acid,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene
(11bR)-2,6-Bis([1,1-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin
1,3,3-Trimethyl-2-[(E)-2-{(3E)-2-[(1-phenyl-1H-tetrazol-5-yl)sulf anyl]-3-[(2E)-2-(1,3,3-trimethyl-1,3-dihydro-2H-indol-2-ylidene)e thylidene]-1-cyclohexen-1-yl}vinyl]-3H-indolium chloride
C39H41ClN6S (660.2801776000001)
12-Ethyl-71,71-dihydroxy-8-isobutylbacteriochlorophyllide c
(+-)-chartaceone C
A dihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5 and 7 and 6-carboxy-1-phenylhex-2-en-1-yl groups at positions 6 and 8 respectively. It has been isolated as a racemate from the bark of Cryptocarya chartacea and exhibits inhibitory activity against dengue virus NS5 polymerase.
(+-)-chartaceone F
A dihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5 and 7 and 6-carboxy-1-phenylhex-1-en-3-yl groups at positions 6 and 8 respectively. It has been isolated as a racemate from the bark of Cryptocarya chartacea and exhibits inhibitory activity against dengue virus NS5 polymerase.
(+-)-chartaceone D
A dihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5 and 7, 6-carboxy-1-phenylhex-2-en-1-yl group at positions 6 and a 6-carboxy-1-phenylhex-1-en-3-yl group at position 8. It has been isolated as a racemate from the bark of Cryptocarya chartacea and exhibits inhibitory activity against dengue virus NS5 polymerase.
(+-)-chartaceone E
A dihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5 and 7, a 6-carboxy-1-phenylhex-2-en-1-yl group at position 8 and 6-carboxy-1-phenylhex-2-en-3-yl groups at position 6. It has been isolated as a racemate from the bark of Cryptocarya chartacea and exhibits inhibitory activity against dengue virus NS5 polymerase.
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxy-3-methylphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
alpha-D-glucopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->2)-6-deoxy-alpha-L-mannopyranosyl-(1->3)-2-O-acetyl-6-deoxy-alpha-L-mannopyranose
[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
5-hydroxy-7-(4-hydroxyphenyl)-2-methyl-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]pyrano[3,2-g]chromen-6-one
[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
Elloramycin A
A member of the class of tetracenomycins that is 8-demethyltetracenomycin C in which the hydroxyl hydrogens at position 8 and 10 a are replaced by a 2,3,4-tri-O-methyl-alpha-L-rhamnosyl and methyl groups respectively.
4,20-bis(acetyloxy)-6-(furan-3-yl)-12,19,21-trihydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylpropanoate
(2e)-8-[(3r,4s,5r)-3-(acetyloxy)-5-{[(2e)-8-[(1s,5r,6s)-5-(acetyloxy)-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2-methyl-6-methylideneoct-2-en-7-ynoyl]oxy}-4-hydroxy-6-oxocyclohex-1-en-1-yl]-2-methyl-6-methylideneoct-2-en-7-ynoic acid
(1s,2r,4r,5r,6s,8r,10r,11s,12r,14r,15r,16s,19r,20r,21s)-20,21-bis(acetyloxy)-6-(furan-3-yl)-4,12,19-trihydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylpropanoate
n-{4-[(3s)-19-{[(2s,4s,5r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-9-methyl-4,14,21-trioxo-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaen-3-yl]butyl}-2,2,2-trifluoroethanimidic acid
18-(acetyloxy)-20-(furan-3-yl)-2,3,4-trihydroxy-5,14,19-trimethyl-8,22-dioxo-9,13,15,21,25-pentaoxaoctacyclo[12.10.1.1⁵,¹².0¹,¹⁶.0³,¹².0⁶,¹¹.0¹¹,¹⁶.0¹⁹,²⁴]hexacosan-17-yl acetate
(1s,2s,4r,5s,7s,9s,10r,11s,12s,13s,14r,15r,16s,17s,22s,23s,24r,25r)-13,14-bis(acetyloxy)-4,22,25-trihydroxy-11,15,17,22,23-pentamethyl-3,21-dioxo-8,20-dioxaheptacyclo[13.10.0.0²,¹².0⁵,¹¹.0⁷,⁹.0¹⁶,²⁴.0¹⁹,²³]pentacos-18-en-10-yl acetate
(2s,3r,4s,5s,6r)-2-(4-{4-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]phenoxy}-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
6-{[(2r)-6,11-dihydroxy-2,5-dimethyl-10-oxo-1-oxa-5-azatetraphen-2-yl]methoxy}-7,11-dihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one
C38H32N2O9 (660.2107702000001)